

Announcements.

Looking to discover a little more about our client companies?
A selection of news and recent announcements can be found here.
Eco Buildings Group PLC – Certification of Environmental Management Award
RNS Number : 2969G Eco Buildings Group PLC 28 April 2025 28 April 2025 Eco Buildings Group PLC ("Eco Buildings" or the "Company") Eco Buildings Group Albania Achieves ISO 14001:2015 Certification for Environmental Management Eco Buildings Group plc (the "Company" or the "Group"), a UK-listed modular……
RNS Number : 2969G
Eco Buildings Group PLC
28 April 2025
28 April 2025
Eco Buildings Group PLC
("Eco Buildings" or the "Company")
Eco Buildings Group Albania Achieves ISO 14001:2015 Certification for Environmental Management
Eco Buildings Group plc (the "Company" or the "Group"), a UK-listed modular construction company, is proud to announce that its Albanian subsidiary, Eco Buildings Group Albania, has been awarded the ISO 14001:2015 certification for its Environmental Management System (EMS). This internationally recognized standard underscores the Group's unwavering commitment to environmental stewardship and sustainable business practices.
Commitment to Environmental Excellence
ISO 14001:2015 is a globally acknowledged standard that provides a framework for organizations to effectively manage their environmental responsibilities. Achieving this certification demonstrates Eco Buildings Group Albania's dedication to minimizing environmental impact, complying with applicable laws and regulations, and continually improving its environmental performance.
The certification encompasses the production and sale of prefabricated, Glass Fibre Reinforced Gypsum (GFRG) load-bearing wall products, highlighting the Company's focus on sustainable building materials that contribute to eco-friendly construction solutions.
Strategic Advantage in Sustainable Construction
In an era where environmental considerations are paramount, obtaining ISO 14001:2015 certification positions Eco Buildings Group Albania at the forefront of sustainable construction in the region. This achievement not only enhances the Company's reputation but also provides a competitive edge in the market, as clients and partners increasingly prioritize environmental responsibility in their selection of suppliers and contractors.
CEO Statement
Sanjay Bowry, CEO of Eco Buildings Group plc, commented:
"Securing the ISO 14001:2015 certification is a significant milestone for Eco Buildings Group Albania and reflects our Group's overarching commitment to sustainability. This accomplishment reinforces our dedication to environmental management and aligns with our strategic vision of delivering innovative, eco-friendly building solutions. We believe that responsible environmental practices are integral to long-term success and value creation for our stakeholders."
Looking Ahead
Eco Buildings Group plc remains steadfast in its pursuit of excellence in environmental management across all its operations. The Company will continue to implement best practices, invest in sustainable technologies, and engage with stakeholders to promote environmental awareness and responsibility.
About Eco Buildings Group plc
Eco Buildings is a leading innovator in prefabricated, green housing products, leveraging proven technology based on GFRG panels. Our modular housing solutions cater to both affordable and high-end housing markets, combining cost efficiency, speed of construction, and sustainability. With a growing portfolio of international projects, Eco Buildings is dedicated to redefining construction for the future.
Further information is available on Eco Buildings website: www.eco-buildings.net
For more information contact:
|
Eco Buildings Group plc Sanjay Bowry, Chief Executive Officer Fiona Hadfield, Finance Director |
Tel: +44 (0) 207 380 0999
|
|
Spark Advisory Partners Limited (Nominated Adviser) Matt Davis / James Keeshan |
Tel: +44 (0) 203 368 3550 |
|
Tavira Securities Limited (Broker) Oliver Stansfield / Jonathan Evans |
Tel: +44 (0) 203 192 1739 |
Notes
The Company has acquired proven and innovative prefabricated technology which has been in development and commercial use since 2006. Eco Buildings' range of prefabricated, green housing products based on glass fibre reinforced gypsum walls ("GFRG") provides a construction solution for both affordable and high-end housing.
Eco Buildings has already secured two sales contracts with major construction companies, one in Albania, the other in Kosovo, which are expected to generate gross sales revenue of approximately up to €38 million in total per annum over the first three years (approximately €114 million in total) following Admission.
The market share for factory-based building technology is expected to grow significantly over the coming years as private developers and the public sector seek to address the substantial and growing deficit in housing stock and issues of construction cost, speed and quality and housing affordability.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABUGDSDBDDGUU
Close4GLOBAL PLC – UK Sport Contract Win
RNS Number : 3799E 4GLOBAL PLC 10 April 2025 10 April 2025 4GLOBAL plc ("4GLOBAL" or "the Company") UK Sport Contract Win 4GLOBAL, a provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, is pleased to announce that,……
RNS Number : 3799E
4GLOBAL PLC
10 April 2025
10 April 2025
4GLOBAL plc
("4GLOBAL" or "the Company")
UK Sport Contract Win
4GLOBAL, a provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, is pleased to announce that, following a competitive tender, it has secured an initial 18-month contract worth c. £0.5m with UK Sport, the non-departmental public body responsible for investing in Olympic and Paralympic sports in the UK, primarily through National Governing Bodies ("NGBs").
Under the agreement, 4GLOBAL will lead a pilot project designed to demonstrate the business value of data and digital investments within the elite UK sporting system and accelerate digital transformation within the NGBs supported by UK Sport.
The pilot will facilitate insight-driven decision making by providing relevant NGBs with accurate, standardised data and improved governance frameworks. Through the project, UK Sport aims to establish a consistent approach to data, make systems work together more smoothly and lay the groundwork for AI-powered innovations in the future.
Delivered through 4GLOBAL's newly launched Insight.OS platform and powered by the company's vast, market-leading dataset – a combination that was key to securing the contract – the project reflects the Company's evolution from developing bespoke solutions to a scalable, product-based offering that can be configured to the needs of each client. In addition, the project will significantly enhance 4GLOBAL's data asset, with new, high-quality data sources from elite sport further strengthening its depth and breadth.
The pilot aims to pave the way for a scalable nationwide data platform encompassing all publicly funded NGBs in the UK and has the potential to develop into a multi-year commercial partnership, mirroring the one 4GLOBAL has in place with Sport England in the community sport space.
Coupled with the recently announced Sport England contract, 4GLOBAL now holds the two most significant data-led contracts in UK publicly funded sport. Together, these competitive wins reinforce the Company's position as the leading provider of sports data in the UK and the partner of choice for public bodies looking to analyse participation trends, enhance performance and maximise the impact of their investments.
This contract aligns with 4GLOBAL's strategic priority of transitioning to higher margin repeatable and recurring revenue Insight Solutions agreements.
Eloy Mazon, CEO of 4GLOBAL, commented:
"We are proud to be supporting UK Sport in delivering this transformative programme for NGBs. It marks another important milestone for 4GLOBAL and, alongside the recent renewal and expansion of our work with Sport England, provides further validation of our shift toward scalable, higher margin Insight Solutions agreements characterised by recurring and repeatable revenue.
Delivered through our Insight.OS platform and powered by our unmatched proprietary dataset, which itself is enriched by this kind of agreement, this contract cements our position as the UK leader in sport data and digital infrastructure. It demonstrates the value of our product-led model, where we are licensing our data asset and providing support to help clients unlock actionable insights, rather than building unique systems from the ground up.
We look forward to working closely with UK Sport and the NGBs to help shape a more connected, insight-driven future for elite sport in the UK. Importantly, this programme also provides a clear blueprint for future initiatives in our key international markets, where the need for powerful and easy-to-use data solutions like ours is growing rapidly."
Contacts
|
4GLOBAL |
via Alma |
|
Eloy Mazon (CEO) Stuart Wooller (Group Finance Director)
|
|
|
Spark Advisory Partners (Nominated Adviser) |
+44 (0)20 3368 3554 |
|
Neil Baldwin
|
|
|
Canaccord Genuity (Broker) |
+44 (0)20 7523 8000 |
|
Bobbie Hilliam
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Rebecca Sanders-Hewett |
4global@almastrategic.com |
|
David Ison Josh Royston Will Ellis Hancock |
|
About 4GLOBAL
4GLOBAL empowers sports, fitness and wellness organisations to make faster, smarter decisions about their operations, customers and investments through data and actionable insights.
It operates the largest sport participation and facility database in the world, with more than 4 billion data points.
Sourcing data from health & fitness operators, community programmes and other structured activities through its DataHub while drawing on information from GPS location updates and wearable devices, 4GLOBAL's unique combination of data assets provides a holistic view of physical activity patterns.
4GLOBAL is at the forefront of predictive modelling and advanced analytics, with the insights it generates empowering customers to drive efficiencies, improve customer relationships and make more informed strategic decisions.
Its customers span both the public and private sectors, including central and local governments, cities, sporting bodies, trade associations, health & fitness operators and sports clubs.
Key markets include North America, the UK and Europe. Its headquarters are in London with offices in Miami and Istanbul.
4GLOBAL was founded in 2002 and listed on AIM in 2021 under the ticker 4GBL.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CNTPKCBQPBKDCQK
CloseSmarttech247 Group PLC – Multi-Year Framework Agreement with London Airport
RNS Number : 7874D Smarttech247 Group PLC 07 April 2025 07 April 2025 Smarttech247 Group PLC ("Smarttech247", the "Group" or the "Company") Smarttech247 awarded Multi-Year Framework Agreement with Major London Airport Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and……
RNS Number : 7874D
Smarttech247 Group PLC
07 April 2025
07 April 2025
Smarttech247 Group PLC
("Smarttech247", the "Group" or the "Company")
Smarttech247 awarded Multi-Year Framework Agreement with Major London Airport
Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, is pleased to announce it has been appointed to a multi-year cybersecurity framework agreement (the "Agreement") with a major international airport in London.
The Agreement has a total potential value of up to £7 million across all four suppliersover its five-year term, with a further one-year extension available. While the Agreement does not guarantee minimum spend, it establishes Smarttech247 as a trusted provider to one of the UK's most high-profile transport hubs, offering a significant opportunity to generate meaningful revenues over the life of the agreement.
Each order under the Agreement will be subject to a separate call-off contract and governed by the framework's standard terms and conditions. The Agreement also provides a flexible mechanism for the customer to procure cybersecurity services from Smarttech247 as needed, including the Company's flagship VisionX platform.
Under the terms of the Agreement, Smarttech247 will be eligible to provide services and solutions under several categories, which include:
· Cybersecurity Support Services –including 24/7 managed detection and response services, firewall maintenance, endpoint and XDR management, dark web monitoring and cybersecurity assessments.
· Cybersecurity Products –advanced email protection, endpoint detection and response technologies and related licencing.
· Security Information and Event Management (SIEM) –next-generation SIEM, internal pen testing, threat intelligence, data discovery and vendor security assessment tools.
Raluca Saceanu, CEO of Smarttech247, commented:
"We are delighted to have been selected for this prestigious framework with one of the UK's busiest international airports. Being selected as one of its preferred suppliers for critical cybersecurity requirements further validates our strong capabilities in managed detection and response, and our ability to support complex, critical infrastructure environments.
"This win reflects the Group's continued execution against its strategy to grow through high-value, long-term engagements with critical national infrastructure clients. It is also a significant opportunity for us to potentially deliver cybersecurity services in a highly regulated and high-security setting over the coming years."
– Ends –
*Smarttech247 is a recognised vendor in 2024 Gartner® Market Guide for Managed Detection and Response.
For further information please contact:
|
Smarttech247 Group PLC |
Tel: +353 21 206 6033 |
|
Ronan Murphy, Executive Chairman Raluca Saceanu, Chief Executive Officer Nicholas Lee, Finance Director |
|
|
SPARK Advisory Partners Limited – Nominated Adviser |
Tel: + 44 (0) 20 3368 3550 |
|
Mark Brady /Angus Campbell |
|
|
Cavendish Capital Markets Limited – Corporate Broker |
Tel: +44 (0) 7220 0500 |
|
Marc Milmo / Hamish Waller Tim Redfern / Sunila de Silva – Broking |
|
|
Yellow Jersey PR Charles Goodwin / Annabelle Wills / Bessie Elliot |
Tel: +44 (0) 20 3004 9512
|
About Smarttech247
Smarttech247 is a multi-award winning automated MDR (Managed Detection & Response) company. Its platform is trusted by international organisations and provides threat intelligence with managed detection and response to provide actionable insights, 24/7 threat detection, investigation and response.
The Group's services are geared towards proactive prevention, and it achieves this by utilising the latest technologies, along with an experienced incident response team.
Smarttech247's offices are located in Ireland, United Kingdom, Romania, Poland and the USA. The Company was admitted to trading on the London Stock Exchange on 15 December 2022.
For further information please visitwww.smarttech247.com
*Gartner disclaimers
Market Guide for Managed Detection and Response, 24 June 2024, Pete Shoard, Andrew Davies, Mitchell Schneider, Angel Berrios, Craig Lawson.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the
U.S. and internationally and is used herein with permission. All rights reserved.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGRUPUPGCUPAGAC
CloseSmarttech247 Group PLC – Multi-Year Framework Agreement with London Airport
RNS Number : 7874D Smarttech247 Group PLC 07 April 2025 07 April 2025 Smarttech247 Group PLC ("Smarttech247", the "Group" or the "Company") Smarttech247 awarded Multi-Year Framework Agreement with Major London Airport Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and……
RNS Number : 7874D
Smarttech247 Group PLC
07 April 2025
07 April 2025
Smarttech247 Group PLC
("Smarttech247", the "Group" or the "Company")
Smarttech247 awarded Multi-Year Framework Agreement with Major London Airport
Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, is pleased to announce it has been appointed to a multi-year cybersecurity framework agreement (the "Agreement") with a major international airport in London.
The Agreement has a total potential value of up to £7 million across all four suppliersover its five-year term, with a further one-year extension available. While the Agreement does not guarantee minimum spend, it establishes Smarttech247 as a trusted provider to one of the UK's most high-profile transport hubs, offering a significant opportunity to generate meaningful revenues over the life of the agreement.
Each order under the Agreement will be subject to a separate call-off contract and governed by the framework's standard terms and conditions. The Agreement also provides a flexible mechanism for the customer to procure cybersecurity services from Smarttech247 as needed, including the Company's flagship VisionX platform.
Under the terms of the Agreement, Smarttech247 will be eligible to provide services and solutions under several categories, which include:
· Cybersecurity Support Services –including 24/7 managed detection and response services, firewall maintenance, endpoint and XDR management, dark web monitoring and cybersecurity assessments.
· Cybersecurity Products –advanced email protection, endpoint detection and response technologies and related licencing.
· Security Information and Event Management (SIEM) –next-generation SIEM, internal pen testing, threat intelligence, data discovery and vendor security assessment tools.
Raluca Saceanu, CEO of Smarttech247, commented:
"We are delighted to have been selected for this prestigious framework with one of the UK's busiest international airports. Being selected as one of its preferred suppliers for critical cybersecurity requirements further validates our strong capabilities in managed detection and response, and our ability to support complex, critical infrastructure environments.
"This win reflects the Group's continued execution against its strategy to grow through high-value, long-term engagements with critical national infrastructure clients. It is also a significant opportunity for us to potentially deliver cybersecurity services in a highly regulated and high-security setting over the coming years."
– Ends –
*Smarttech247 is a recognised vendor in 2024 Gartner® Market Guide for Managed Detection and Response.
For further information please contact:
|
Smarttech247 Group PLC |
Tel: +353 21 206 6033 |
|
Ronan Murphy, Executive Chairman Raluca Saceanu, Chief Executive Officer Nicholas Lee, Finance Director |
|
|
SPARK Advisory Partners Limited – Nominated Adviser |
Tel: + 44 (0) 20 3368 3550 |
|
Mark Brady /Angus Campbell |
|
|
Cavendish Capital Markets Limited – Corporate Broker |
Tel: +44 (0) 7220 0500 |
|
Marc Milmo / Hamish Waller Tim Redfern / Sunila de Silva – Broking |
|
|
Yellow Jersey PR Charles Goodwin / Annabelle Wills / Bessie Elliot |
Tel: +44 (0) 20 3004 9512
|
About Smarttech247
Smarttech247 is a multi-award winning automated MDR (Managed Detection & Response) company. Its platform is trusted by international organisations and provides threat intelligence with managed detection and response to provide actionable insights, 24/7 threat detection, investigation and response.
The Group's services are geared towards proactive prevention, and it achieves this by utilising the latest technologies, along with an experienced incident response team.
Smarttech247's offices are located in Ireland, United Kingdom, Romania, Poland and the USA. The Company was admitted to trading on the London Stock Exchange on 15 December 2022.
For further information please visitwww.smarttech247.com
*Gartner disclaimers
Market Guide for Managed Detection and Response, 24 June 2024, Pete Shoard, Andrew Davies, Mitchell Schneider, Angel Berrios, Craig Lawson.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the
U.S. and internationally and is used herein with permission. All rights reserved.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGRUPUPGCUPAGAC
CloseSilverwood Brands plc – Leading Balmonds product now available at Boots
RNS Number : 5742D Silverwood Brands PLC 03 April 2025 3 April 2025 Silverwood Brands plc ("Silverwood", the "Company" or, together with its subsidiaries, the "Group") Leading Balmonds product now available in Boots stores and on Boots.com Silverwood Brands plc (AQSE: SLWD) is pleased to announce that……
RNS Number : 5742D
Silverwood Brands PLC
03 April 2025
3 April 2025
Silverwood Brands plc
("Silverwood", the "Company" or, together with its subsidiaries, the "Group")
Leading Balmonds product now available in Boots stores and on Boots.com
Silverwood Brands plc (AQSE: SLWD) is pleased to announce that Balmonds' flagship product, Skin Salvation, is now available in Boots stores and online at Boots.com.
Made with beeswax, organic oils and herbal tinctures, Skin Salvation is an award winning, 100% natural barrier balm, designed to prevent and treat the symptoms of eczema, psoriasis, and other dry skin conditions.
Alongside Skin Salvation, Balmonds produces a range of skin care solutions, including, creams, oils and salves, all based around natural and organic active ingredients. The Balmonds range is available directly from Balmonds.co.uk, as well as through channels including Amazon and Holland & Barrett. A wider range of Balmonds products will also be available soon on Boots.com.
Andrew Gerrie, Executive Director at Silverwood, said, "Balmonds is one of Silverwood's core brands. Its hero product, Skin Salvation, is now available in over 300 Boots stores, and on Boots.com.
Roughly 10% of people in the UK are estimated to have eczema at some point in their lives and at least 50% consider themselves as having sensitive skin. The addition of Boots to our distribution channels should help significantly increase the reach of Balmonds and our share of the market for sensitive skin solutions."
For more information, please contact:
|
Silverwood Brands Plc Andrew Gerrie Paul Hodgins
|
|
|
Peterhouse Capital Limited(Aquis Corporate Adviser) Mark Anwyl Narisha Ragoonanthun Brefo Gyasi
|
+44 (0)20 7469 0930 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFXLFBEZLXBBB
Close4GLOBAL plc – Sport England Contract Renewal and Expansion
RNS Number : 4257D 4GLOBAL PLC 03 April 2025 3 April 2025 4GLOBAL plc ("4GLOBAL" or "the Company") Sport England Contract Renewal and Expansion 4GLOBAL, a provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, is pleased……
RNS Number : 4257D
4GLOBAL PLC
03 April 2025
3 April 2025
4GLOBAL plc
("4GLOBAL" or "the Company")
Sport England Contract Renewal and Expansion
4GLOBAL, a provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, is pleased to announce that, following a competitive tender, it has secured a contract renewal and expansion with Sport England worth up to £4m over four years in equal terms.
Sport England initially procured 4GLOBAL in 2021 to provide performance data from public leisure facilities through its platform, Moving Communities, a decision-support tool that uses 4GLOBAL's dataset to aid understanding of where and how people engage in physical activity, enabling a more evidence-based approach to public investment. The platform has since played a central role in programmes such as the National Leisure Recovery Fund and the Swimming Pool Support Fund, tracking over 9 million active people across 1,000+ leisure facilities daily.
This new Insight Solutions contract marks a significant expansion of the Sport England Moving Communities programme, underpinned by the Company's recently launched Insight.OS platform. 4GLOBAL's dataset now goes far beyond data public leisure facilities, incorporating a wide range of external sources such as wearable movement data and participation in community events, enabling broader and more detailed insights into physical activity patterns across the population with an unprecedented level of accuracy.
The expansion will support the delivery of Sport England's £250 million place-based investment strategy, enabling local and national bodies to use data-driven insights to target resources more effectively, overcome barriers to physical activity, monitor impact in real time, adjust delivery where needed and demonstrate to stakeholders that funding is being deployed effectively to maximise returns and drive meaningful outcomes.
Under the new agreement, 4GLOBAL will provide data and actionable insight to the wider ecosystem of sport and physical activity in England, engaging national governing bodies, local authorities, sports bodies and community programme providers to enable large scale, coordinated and effective delivery.
The increased breadth and depth of 4GLOBAL's dataset, now the largest repository of its kind in the UK, and its proven ability to generate actionable insights, were pivotal in securing the contract renewal and expansion.
Eloy Mazon, 4GLOBALCEO, said:"This new agreement is a strong endorsement of our ability to deepen and expand client relationships, which continues to lower our customer acquisition costs and drive EBITDA margin improvement. It also reflects the shift in our commercial model, with multi-year, multi-million-pound contracts underpinning our transition to Annual Recurring and Repeatable Revenue.
"The migration of clients to Insight Solutions is already delivering meaningful profitability gains, and the strength of our dataset not only enables us to offer richer insights to partners like Sport England but also reinforces a defensible competitive moat around our business. Wins like this contribute to a growing base of forward-looking revenue and position us well for long-term growth."
Contacts
|
4GLOBAL |
via Alma |
|
Eloy Mazon (CEO) |
|
|
Stuart Wooller (Group Finance Director) |
|
|
|
|
|
Spark Advisory Partners (Nominated Adviser) |
+44 (0)20 3368 3554 |
|
Neil Baldwin |
|
|
|
|
|
Canaccord Genuity (Broker) |
+44 (0)20 7523 8000 |
|
Bobbie Hilliam |
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Rebecca Sanders-Hewett |
|
|
David Ison |
|
|
Louisa El-Ahwal |
|
|
Josh Royston |
|
|
Will Ellis Hancock |
|
About 4GLOBAL
4GLOBAL empowers sports, fitness and wellness organisations to make faster, smarter decisions about their operations, customers and investments through data and actionable insights.
It operates the largest sport participation and facility database in the world, with more than 4 billion data points.
Sourcing data from health & fitness operators, community programmes and other structured activities through its DataHub while drawing on information from GPS location updates and wearable devices, 4GLOBAL's unique combination of data assets provides a holistic view of physical activity patterns.
4GLOBAL is at the forefront of predictive modelling and advanced analytics, with the insights it generates empowering customers to drive efficiencies, improve customer relationships and make more informed strategic decisions.
Its customers span both the public and private sectors, including central and local governments, cities, sporting bodies, trade associations, health & fitness operators and sports clubs.
Key markets include North America, the UK and Europe. Its headquarters are in London with offices in Miami and Istanbul.
4GLOBAL was founded in 2002 and listed on AIM in 2021 under the ticker 4GBL.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CNTQLLFBEZLZBBL
Closegenedrive plc – Additional grant funding under DEVOTE programme
RNS Number : 2449D Genedrive PLC 02 April 2025 genedrive plc ("genedrive" or the "Company") Genedrive awarded additional grant funding under the DEVOTE programme genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces the extension of the highly successful multi-partner grant award from Innovate UK……
RNS Number : 2449D
Genedrive PLC
02 April 2025
genedrive plc
("genedrive" or the "Company")
Genedrive awarded additional grant funding under the DEVOTE programme
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces the extension of the highly successful multi-partner grant award from Innovate UK and the UK Government's Innovation Accelerator programme.
The Development and Validation of Technology for Time Critical Genomic Testing ("DEVOTE") grant, saw the Company benefit from approximately £1.2m through a combination of direct grant income, in-kind partner contributions, and other aligned funding. The DEVOTE programme provided the Company with acute care patient access and supporting infrastructure to assess the real-world clinical performance of time-critical clinical tests in NHS settings. The programme's lead partner, the University of Manchester ("UoM"), has supported the evaluation, validation, and implementation of the Genedrive® CYP2C19 ID Kit.
During the DEVOTE programme the Company completed validation and UKCA certification of the Genedrive® CYP2C19-ID Kit, which was subsequently published in the Journal of Molecular Diagnostics in December 2024 and recommended in final guidance from the UK's National Institute for Health and Care Excellence ("NICE") as the rapid genetics platform of choice for use in the NHS for Clopidogrel genotyping after Ischaemic or Transient Ischaemic Attack.
The significant success of the DEVOTE programme has led to follow-on Innovate UK Innovation Accelerator funding to further progress the DEVOTE project, of which the Company will receive £0.2m directly over the next six months for continuation of implementation of user-led product enhancements which are expected to further improve user experiences in rapid genetic testing environments.
Gino Miele, Chief Executive Officer of genedrive plc, said: "The DEVOTE programme has been an incredible success and follow-on funding provides a further opportunity for us to partner once again with the University of Manchester in continuing development of time-critical genetic test solutions. The additional non-dilutive grant funding facilitates the mitigation of development costs that would otherwise have been absorbed by the Company."
For further details please contact:
|
genedrive plc |
+44 (0)161 989 0245 |
|
Gino Miele: CEO / Russ Shaw: CFO |
|
|
|
|
|
Peel Hunt LLP (Nominated Adviser and Broker) |
+44 (0)20 7418 8900 |
|
James Steel |
|
|
|
|
|
Walbrook PR Ltd (Media & Investor Relations) |
+44 (0)20 7933 8780 orgenedrive@walbrookpr.com |
|
Anna Dunphy |
+44 (0)7876 741 001 |
About genedrive plc (http://www.genedriveplc.com)
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive® MT-RNR1 ID Kit and the Genedrive® CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive® MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence ("NICE") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.
About DEVOTE
The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) Programme is a collaboration between academics, clinicians, and industry partners. It aims to accelerate the adoption of genomic technology into clinical practice by supporting companies through each aspect of the translational pathway.
Programme information is available at:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCIBMBTMTTMTBA
CloseGenedrive PLC – Additional grant funding under DEVOTE programme
RNS Number : 2449D Genedrive PLC 02 April 2025 genedrive plc ("genedrive" or the "Company") Genedrive awarded additional grant funding under the DEVOTE programme genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces the extension of the highly successful multi-partner grant award from Innovate UK……
RNS Number : 2449D
Genedrive PLC
02 April 2025
genedrive plc
("genedrive" or the "Company")
Genedrive awarded additional grant funding under the DEVOTE programme
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces the extension of the highly successful multi-partner grant award from Innovate UK and the UK Government's Innovation Accelerator programme.
The Development and Validation of Technology for Time Critical Genomic Testing ("DEVOTE") grant, saw the Company benefit from approximately £1.2m through a combination of direct grant income, in-kind partner contributions, and other aligned funding. The DEVOTE programme provided the Company with acute care patient access and supporting infrastructure to assess the real-world clinical performance of time-critical clinical tests in NHS settings. The programme's lead partner, the University of Manchester ("UoM"), has supported the evaluation, validation, and implementation of the Genedrive® CYP2C19 ID Kit.
During the DEVOTE programme the Company completed validation and UKCA certification of the Genedrive® CYP2C19-ID Kit, which was subsequently published in the Journal of Molecular Diagnostics in December 2024 and recommended in final guidance from the UK's National Institute for Health and Care Excellence ("NICE") as the rapid genetics platform of choice for use in the NHS for Clopidogrel genotyping after Ischaemic or Transient Ischaemic Attack.
The significant success of the DEVOTE programme has led to follow-on Innovate UK Innovation Accelerator funding to further progress the DEVOTE project, of which the Company will receive £0.2m directly over the next six months for continuation of implementation of user-led product enhancements which are expected to further improve user experiences in rapid genetic testing environments.
Gino Miele, Chief Executive Officer of genedrive plc, said: "The DEVOTE programme has been an incredible success and follow-on funding provides a further opportunity for us to partner once again with the University of Manchester in continuing development of time-critical genetic test solutions. The additional non-dilutive grant funding facilitates the mitigation of development costs that would otherwise have been absorbed by the Company."
For further details please contact:
|
genedrive plc |
+44 (0)161 989 0245 |
|
Gino Miele: CEO / Russ Shaw: CFO |
|
|
|
|
|
Peel Hunt LLP (Nominated Adviser and Broker) |
+44 (0)20 7418 8900 |
|
James Steel |
|
|
|
|
|
Walbrook PR Ltd (Media & Investor Relations) |
+44 (0)20 7933 8780 orgenedrive@walbrookpr.com |
|
Anna Dunphy |
+44 (0)7876 741 001 |
About genedrive plc (http://www.genedriveplc.com)
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive® MT-RNR1 ID Kit and the Genedrive® CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive® MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence ("NICE") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.
About DEVOTE
The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) Programme is a collaboration between academics, clinicians, and industry partners. It aims to accelerate the adoption of genomic technology into clinical practice by supporting companies through each aspect of the translational pathway.
Programme information is available at:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCIBMBTMTTMTBA
CloseNorthcoders Group PLC – New Consultancy contract wins
RNS Number : 9938C Northcoders Group PLC 01 April 2025 This is a Reach (i.e. non-regulatory) announcement, and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance 1April2025 Northcoders Group PLC ('Northcoders', the……
RNS Number : 9938C
Northcoders Group PLC
01 April 2025
This is a Reach (i.e. non-regulatory) announcement, and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance
|
|
1April2025 |
Northcoders Group PLC
('Northcoders', the 'Group' or the 'Company')
New Consultancy contract wins
Northcoders to provide digital training to leading UK Building Society
and Manchester Airports Group
Northcoders (AIM:CODE), a market leader in technology training in the UK, is pleased to announce that its consultancy brand, Counter® has secured new contracts with Skipton Building Society ('Skipton'), one of the leading UK-based mutual financial services groups, and Manchester Airports Group ('MAG').
Following the successful integration of a Data Engineering team in 2024, Skipton has agreed terms for a second consultancy contract with Counter® in line with its strategy to grow internal capabilities and deliver its ambitious technology strategy. This team is supporting the delivery of the Society's brand-new customer web and mobile applications for its members using the Northcoders business model of deploying advanced engineers from Northcoders alumni and the Group's Tech Returners business. Beyond the immediate delivery to Skipton's members, a key benefit to the Society is the option for the Consultants to join Skipton for the next stage of their career.
Following an initial six-month engagement with MAG, a further three-month contract extension has been agreed. The embedded team of technologists will be working on a project to enhance MAG's three airport websites, and delivering an improved mobile experience.
Chris Hill, CEO of Northcoders, said:"We are delighted to announce the new contracts for our consultancy division, reflecting the recent progress made by Counter® in disrupting the traditional, hire, train, deploy market. With a focus specifically on the underserved technology training market, and offering the best-in-class Consultants, we are beginning to build a brand, relationships and pipeline to take material market share in the medium term, particularly with return customers like Manchester Airports Group.
"This demonstrates the successful diversification of Northcoders revenues as we mature as a business, addressing the UK's significant digital skills gap in private and public services and meeting technology transformation aspirations over the coming years."
June Powell, Engineering Enablement Lead, Skipton Building Society, said:"I had the pleasure of working with Counter® last year on a project, and I am delighted to have the opportunity to collaborate with them again in a different area of our business. I look forward to seeing more of their skills and experience in action as they continue to support The Society in our ongoing evolution. Their collaborative approach and the time they dedicate to truly understanding our culture make them an ideal fit for Skipton."
– Ends –
|
For further enquiries:
|
|
|
||||||||||||||||||||||||
Notes to Editors
Northcoders is a market leading provider of technology training for businesses and individuals with courses in, Software Engineering, Data Engineering, AI and Machine Learning, and Platform Engineering. Founded in 2015, the Group provides the highest quality online training to students across the UK via its proven NCore technology platform.
Powered by IP rich technology, Northcoders offers boot camp courses to individuals from a range of backgrounds, delivered through virtual and physical learning. The Group also works with blue chip corporates across multiple sectors to help them to achieve their digital requirements, with teams as a service and to supply innovative solutions for the upskilling and reskilling of employees. With a keen focus of inclusivity, diversity and quality at its core, Northcoders aims to address the digital skills gap in the UK to meet the increasing demand for digital specialists at all levels, from businesses and public agencies.
Northcoders was admitted to trading on AIM in July 2021 with the ticker CODE.L. For additional information please visitinvestors.northcodersgroup.com.
About Counter®
Counter®specialises in deploying UK-based teams of technologists into corporate clients, building dedicated teams that align technically and culturally with clients' long-term goals. Counter®is a challenger brand to the current tech consultancy, Offshore and Hire, Train and Deploy sector by offering a different approach underpinned by an efficient and scalable business model based on 100% utilisation rates for its Counter®consultants.
Counter®'s Consultants have either completed Northcoders' training and are proficient in modern cloud and software solutions, including AI/ML development, data and cloud engineering or are part of the Tech Returners network. The consultancy's robust model ensures that at the end of each engagement, clients have the option to onboard the consultants as full-time employees ('FTEs'), at no additional cost, reinforcing skill retention and continuity.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABUGDXCSXDGUB
CloseCroma Security Solutions Group PLC – Acquisition
RNS Number : 9559C Croma Security Solutions Group PLC 01 April 2025 01 April 2025 Croma Security Solutions Group Plc ("CSSG", "Croma", "the "Company" or the "Group") Acquisition of Peterborough Locksmith Croma Security Solutions Group plc (AIM:CSSG) is pleased to announce that it has completed the acquisition of……
RNS Number : 9559C
Croma Security Solutions Group PLC
01 April 2025
01 April 2025

Croma Security Solutions Group Plc
("CSSG", "Croma", "the "Company" or the "Group")
Acquisition of Peterborough Locksmith
Croma Security Solutions Group plc (AIM:CSSG) is pleased to announce that it has completed the acquisition of Benn Lock and Safe Limited ("Benn Lock & Safe"), a well-established, Peterborough based locksmith and security provider for a total consideration of £200,000, to be satisfied as to £166,667 in cash and the balance through the issue of 38,535 ordinary shares which will be issued from Treasury at an issue price of 86.50 pence per share ("Consideration Shares"), representing average of the closing middle quotations over the five dealing days ending on the dealing day immediately before the completion Date.
Benn Lock & Safe was founded nearly 50 years ago, originally operating as a pure locksmith service before expanding into fire and electronic security solutions. The business has developed specialist expertise in servicing schools and multi-occupancy properties and is trusted by local vendors, police forces, and government sectors across Cambridgeshire. Benn Lock & Safe has developed its reputation through both a physical storefront in Peterborough and a successful online presence.
Croma already has a locksmith store in Peterborough, operating less than two miles from Benn Lock & Safe. The acquisition will enable Benn Lock & Safe to be combined with Croma's Peterborough branch, consolidating the two businesses into a single security centre. This will naturally create immediate cost savings and synergies but equally importantly, it will become the sole centre for security and locksmith services in the Peterborough area. The lease on the Benn Lock & Safe retail property allows for a 12-month break clause.
For the 12 months to 31 March 2024 Benn Lock & Safe generated revenues of £675,000 and profit before tax of £40,000. As at 28 February 2025, the net asset value of the assets being acquired was £90,000.
Phil Hunt, Managing Director of Benn Lock & Safe, said: "We have always prided ourselves on delivering expert locksmith and security services to our customers, and I am looking forward to continuing to do so as part of Croma. The Group's well-established model will provide us with the operational support and resources to enhance our offering while maintaining the trusted service that Benn Lock & Safe is known for."
Roberto Fiorentino, Chief Executive Officer, commented:"We are very pleased to welcome Benn Lock & Safe into the Group. This is a strategic acquisition for us, and also one that further evidences our acquisition model gaining traction, with independent locksmiths recognising the benefits of being part of our network. Benn Lock & Safe has seen first-hand how another locksmith in the area has successfully integrated into our proven model, which gave them confidence in making this transition. We believe this trend will continue, as we progress our pipeline of acquisition opportunities."
Total Voting Rights
Following the issue of the Consideration Shares from Treasury, the Company will continue to have 15,898,656 Ordinary Shares in issue, but with 2,130,401 held in treasury. Accordingly, the total number of voting rights in the Company will be 13,768,255 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information visit www.cssgroupplc.com or contact:
Croma Security Solutions Group Plc Tel: +44 44 (0)1489 566 166
Roberto Fiorentino, CEO
Teo Andreeva, CFO
Zeus Tel: +44 (0)207 220 1666
(Nominated Adviser and Broker)
Mike Coe
James Bavister
Novella Tel: +44 (0)203 151 7008
Tim Robertson
Chris Marsh
Safia Colebrook
Notes to editors:
Croma Security Solutions is an expanding technology led security solutions provider with over 50 years of specialist experience, delivering high-quality security solutions across locksmith, fire and security services for both domestic and commercial environments. The Groups network currently stands at 17 security centres, stretching from its headquarters in Southampton, across the Midlands and up to the Northwest. Croma services a range of sectors including health, education, leisure and entertainment, and utilities, and is trusted by national brands, including multiple NHS Trusts, with their complex security needs.
Croma's growth strategy is focused on establishing a national security network. In 2023, it sold its man-guarding business Vigilant for £6.5m, which has provided the capital to fund the expansion of the business. Croma is a proven acquirer of local, traditional locksmith businesses, which are developed into its network of modern security centres, offering both total security solutions and locksmith services to retail and commercial customers. The new security centres benefit from extended product ranges, centralised group services, and both a local and national customer base. Since the sale in 2023, Croma has added new businesses to its network, and has a strong pipeline of further locksmiths stores to be acquired into the network.
Croma is listed on the AIM market of the London Stock Exchange. Founded in 1970, it is headquartered in Southampton and has over 90 employees.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQJBMBTMTJJBLA
Close
Neville Registrars Limited, Neville House, Steelpark Road, Halesowen, B62 8HD
Tel: 0121 585 1131
Email: info@nevilleregistrars.co.uk

© Neville Registrars Limited 2026. All Rights Reserved. Registered in England No. 4770411
